Viruses Paramyxovir là tác nhân điều trị ung thư: Cơ chế hoạt động, Nghiên cứu tiền lâm sàng và Lâm sàng

citation_journal_title=Am. J. Med. Sci.; citation_title=The influence of complicating diseases upon leukemia; citation_author=G. Dock; citation_volume=127; citation_publication_date=1904; citation_pages=563-592; citation_doi=10.1097/00000441-190412740-00001; citation_id=CR1 citation_journal_title=Ginecologia.; citation_title=Sulla scomparsa di un enorme cancro vegetante del collo dell’utero senza cura chirurgica; citation_author=N. Pace; citation_volume=9; citation_publication_date=1912; citation_pages=82-89; citation_id=CR2 citation_journal_title=Inst. Pasteur.; citation_title=Vaccine et neoplasmes Ann; citation_author=C. Levaditi, S. Nicolau; citation_volume=37; citation_publication_date=1923; citation_pages=443-447; citation_id=CR3 citation_journal_title=N. Engl. J. Med.; citation_title=Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid; citation_author=S. Farber, L.K. Diamond; citation_volume=238; citation_publication_date=1948; citation_pages=787-793; citation_doi=10.1056/NEJM194806032382301; citation_id=CR4 citation_journal_title=Lek. Listy.; citation_title=Viruses and tumors; citation_author=J. Svejda; citation_volume=5; citation_publication_date=1950; citation_pages=688-689; citation_id=CR5 citation_journal_title=Annu. Rev. Microbiol.; citation_title=Effects of viruses on tumors; citation_author=A.E. Moore; citation_volume=8; citation_publication_date=1954; citation_pages=393-410; citation_doi=10.1146/annurev.mi.08.100154.002141; citation_id=CR6 citation_journal_title=Mol. Ther.; citation_title=History of oncolytic viruses: Genesis to genetic engineering; citation_author=E. Kelly, S.J. Russell; citation_volume=15; citation_publication_date=2007; citation_pages=651-659; citation_doi=10.1038/sj.mt.6300108; citation_id=CR7 citation_journal_title=Epidemiol. Sanit. (Moscow).; citation_title=Oncolytic viruses: Achievements and problems; citation_author=S.V. Netesov, G.V. Kochneva, V.A. Svyatchenko; citation_volume=13; citation_publication_date=2011; citation_pages=10-17; citation_id=CR8 citation_journal_title=Mol. Genet. Microbiol. Virol. (Moscow); citation_title=Oncolytic poxviruses; citation_author=G.V. Kochneva, G.F. Sivolobova, K.V. Yudina; citation_volume=27; citation_issue=1; citation_publication_date=2012; citation_pages=7-15; citation_doi=10.3103/S0891416812010041; citation_id=CR9 citation_journal_title=New approaches to the treatment of cancer. Bull. Russ. Acad. Med. Sci.; citation_title=Oncolytic parvoviruses; citation_author=V.B. Loktev, T.Yu. Ivankina, S.V. Netesov, P.M. Chumakov; citation_volume=67; citation_publication_date=2012; citation_pages=42-47; citation_id=CR10 citation_journal_title=Mol. Biol. (Moscow).; citation_title=Oncolytic adenoviruses in anticancer therapy: Current status and prospects; citation_author=V.A. Svyatchenko, M.V. Tarasova, S.V. Netesov, P.M. Chumakov; citation_volume=46; citation_publication_date=2012; citation_pages=496-507; citation_doi=10.1134/S0026893312040103; citation_id=CR11 citation_journal_title=EBioMedicine.; citation_title=Oncolytic viruses: Therapeutics with an identity crisis; citation_author=C.J. Breitbach, B.D. Lichty, J.C. Bell; citation_volume=9; citation_publication_date=2016; citation_pages=31-36; citation_doi=10.1016/j.ebiom.2016.06.046; citation_id=CR12 citation_journal_title=Cancer Sci.; citation_title=Oncolytic virus therapy: A new era of cancer treatment at dawn; citation_author=H. Fukuhara, Y. Ino, T. Todo; citation_volume=107; citation_publication_date=2016; citation_pages=1373-1379; citation_doi=10.1111/cas.13027; citation_id=CR13 citation_journal_title=Clin. Cancer Res.; citation_title=Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies; citation_author=E.M. Karapanagiotou, V. Roulstone, K. Twigger; citation_volume=18; citation_publication_date=2012; citation_pages=2080-2089; citation_doi=10.1158/1078-0432.CCR-11-2181; citation_id=CR14 citation_journal_title=Nat. Med.; citation_title=Randomized dosefinding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer; citation_author=J. Heo, T. Reid, L. Ruo; citation_volume=19; citation_publication_date=2013; citation_pages=329-336; citation_doi=10.1038/nm.3089; citation_id=CR15 citation_journal_title=Nat. Rev. Drug Discov.; citation_title=Oncolytic viruses get a boost with first FDA-approval recommendation; citation_author=E. Dolgin; citation_volume=14; citation_publication_date=2015; citation_pages=369-371; citation_doi=10.1038/nrd4643; citation_id=CR16 citation_journal_title=Melanoma Res.; citation_title=Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study; citation_author=S. Donina, I. Strele, G. Proboka; citation_volume=25; citation_publication_date=2015; citation_pages=421-426; citation_doi=10.1097/CMR.0000000000000180; citation_id=CR17 citation_journal_title=Nature.; citation_title=Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence; citation_author=A. Takaoka, S. Hayakawa, H. Yanai; citation_volume=424; citation_publication_date=2003; citation_pages=516-523; citation_doi=10.1038/nature01850; citation_id=CR18 citation_journal_title=Nature.; citation_title=Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage; citation_author=N. Tanaka, M. Ishihara, M.S. Lamphier; citation_volume=382; citation_publication_date=1996; citation_pages=816-818; citation_doi=10.1038/382816a0; citation_id=CR19 citation_journal_title=Mol. Biol. Cell.; citation_title=DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation; citation_author=O. Moiseeva, F.A. Mallette, U.K. Mukhopadhyay; citation_volume=17; citation_publication_date=2006; citation_pages=1583-1592; citation_doi=10.1091/mbc.e05-09-0858; citation_id=CR20 citation_journal_title=Arch. Immunol. Ther. Exp.; citation_title=The genes of interferons and interferonrelated factors: Localization and relationships with chromosome aberrations in cancer; citation_author=O. Haus; citation_volume=48; citation_publication_date=2000; citation_pages=95-100; citation_id=CR21 citation_journal_title=J. Virol.; citation_title=Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells; citation_author=M. Mansour, P. Palese, D. Zamarin; citation_volume=85; citation_publication_date=2011; citation_pages=6015-6023; citation_doi=10.1128/JVI.01537-10; citation_id=CR22 citation_journal_title=Immunotherapy.; citation_title=New perspectives in cancer virotherapy: Bringing the immune system into play; citation_author=N. Boisgerault, F. Tangy, M. Gregoire; citation_volume=2; citation_publication_date=2010; citation_pages=185-199; citation_doi=10.2217/imt.10.6; citation_id=CR23 citation_journal_title=Hum. Gene Ther.; citation_title=The case of oncolytic viruses versus the immune system: Waiting on the judgment of Solomon; citation_author=R.J. Prestwich, F. Errington, R.M. Diaz; citation_volume=20; citation_publication_date=2009; citation_pages=1119-1132; citation_doi=10.1089/hum.2009.135; citation_id=CR24 citation_journal_title=Gene Ther.; citation_title=Measles virus causes immunogenic cell death in human melanoma; citation_author=O.G. Donnelly, F. Errington-Mais, L. Steele; citation_volume=20; citation_publication_date=2011; citation_pages=7-15; citation_doi=10.1038/gt.2011.205; citation_id=CR25 citation_journal_title=Mol. Cancer.; citation_title=Oncolytic viruses as therapeutic cancer vaccines; citation_author=D.L. Bartlett, Z. Liu, M. Sathaiah; citation_volume=12; citation_publication_date=2013; citation_pages=103; citation_doi=10.1186/1476-4598-12-103; citation_id=CR26 citation_journal_title=Nat. Biotechnol.; citation_title=Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins; citation_author=Y.A. Yu, S. Shabahang, T.M. Timiryasova; citation_volume=22; citation_publication_date=2004; citation_pages=313-320; citation_doi=10.1038/nbt937; citation_id=CR27 citation_journal_title=Mol. Ther.; citation_title=Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine; citation_author=C.G. Lemay, J.L. Rintoul, A. Kus; citation_volume=20; citation_publication_date=2012; citation_pages=1791-1799; citation_doi=10.1038/mt.2012.128; citation_id=CR28 citation_journal_title=J. Vasc. Interv. Radiol.; citation_title=Oncolytic virotherapy; citation_author=D.Y. Sze, T.R. Reid, S.C. Rose; citation_volume=24; citation_publication_date=2013; citation_pages=1115-1122; citation_doi=10.1016/j.jvir.2013.05.040; citation_id=CR29 citation_journal_title=Clin. Cancer Res.; citation_title=Perioperative influenza vaccination reduces postoperative metastatic disease by reversing surgery-induced dysfunction in natural killer cells; citation_author=L.H. Tai, J. Zhang, K.J. Scott; citation_volume=19; citation_publication_date=2013; citation_pages=5104-5115; citation_doi=10.1158/1078-0432.CCR-13-0246; citation_id=CR30 citation_journal_title=Mol. Ther. Oncolytics.; citation_title=Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency; citation_author=O.V. Matveeva, Z.S. Guo, S.A. Shabalina, P.M. Chumakov; citation_volume=2; citation_publication_date=2015; citation_pages=15011; citation_doi=10.1038/mto.2015.11; citation_id=CR31 citation_title=Paramyxoviruses; citation_publication_date=1996; citation_id=CR32; citation_author=G. Enders citation_journal_title=Adv. Exp. Med. Biol.; citation_title=Paramyxovirus entry; citation_author=K.N. Bossart, D.L. Fusco, C.C. Broder; citation_volume=790; citation_publication_date=2013; citation_pages=95-127; citation_doi=10.1007/978-1-4614-7651-1_6; citation_id=CR33 citation_journal_title=Top. Curr. Chem.; citation_title=Sialic acid receptors of viruses; citation_author=M. Matrosovich, G. Herrler, H.D. Klenk; citation_volume=7; citation_publication_date=2013; citation_pages=73; citation_id=CR34 citation_journal_title=Biochim. Biophys. Acta.; citation_title=Sweet escape: Sialic acids in tumor immune evasion; citation_author=C. Bull, M.H. Brok, G.J. Adema; citation_volume=1846; citation_publication_date=2014; citation_pages=238-246; citation_id=CR35 citation_journal_title=Cancer Res.; citation_title=Sialic acids sweeten a tumor’s life; citation_author=C. Bull, M.A. Stoel, M.H. Brok, G.J. Adema; citation_volume=74; citation_publication_date=2014; citation_pages=3199-3204; citation_doi=10.1158/0008-5472.CAN-14-0728; citation_id=CR36 citation_journal_title=Int. J. Cancer.; citation_title=Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle; citation_author=Y. Kawaguchi, Y. Miyamoto, T. Inoue, Y. Kaneda; citation_volume=124; citation_publication_date=2009; citation_pages=2478-2487; citation_doi=10.1002/ijc.24234; citation_id=CR37 citation_journal_title=Glycoconj. J.; citation_title=Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview; citation_author=E. Villar, I.M. Barroso; citation_volume=23; citation_publication_date=2006; citation_pages=5-17; citation_doi=10.1007/s10719-006-5433-0; citation_id=CR38 citation_journal_title=Cancer Res.; citation_title=High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus; citation_author=B.D. Anderson, T. Nakamura, S.J. Russell, K.W. Peng; citation_volume=64; citation_publication_date=2004; citation_pages=4919-4926; citation_doi=10.1158/0008-5472.CAN-04-0884; citation_id=CR39 citation_journal_title=Anticancer Res.; citation_title=CD46 expression is indicative of shorter revival-free survival for ovarian cancer patients; citation_author=P. Surowiak, V. Materna, A. Maciejczyk; citation_volume=26; citation_publication_date=2006; citation_pages=4943-4948; citation_id=CR40 citation_journal_title=Appl. Immunohistochem. Mol. Morphol.; citation_title=CD46 expression is an unfavorable prognostic factor in breast cancer cases; citation_author=A. Maciejczyk, J. Szelachowska, B. Szynglarewicz; citation_volume=19; citation_publication_date=2011; citation_pages=540-546; citation_doi=10.1097/PAI.0b013e31821a0be9; citation_id=CR41 citation_journal_title=PLoS Pathog.; citation_title=Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus; citation_author=R.S. Noyce, D.G. Bondre, M.N. Ha; citation_volume=7; citation_publication_date=2011; citation_pages=1002240; citation_doi=10.1371/journal.ppat.1002240; citation_id=CR42 citation_journal_title=Trends Microbiol.; citation_title=Nectin 4 is the epithelial cell receptor for measles virus; citation_author=R.S. Noyce, C.D. Richardson; citation_volume=20; citation_publication_date=2012; citation_pages=429-439; citation_doi=10.1016/j.tim.2012.05.006; citation_id=CR43 citation_journal_title=J. Biol. Chem.; citation_title=Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alphaconverting enzyme (TACE)/ADAM-17; citation_author=S. Fabre-Lafay, S. Garrido-Urbani, N. Reymond; citation_volume=280; citation_publication_date=2005; citation_pages=19543-19550; citation_doi=10.1074/jbc.M410943200; citation_id=CR44 citation_journal_title=Am. J. Clin. Pathol.; citation_title=Nectin 4 overexpression in ovarian cancer tissues and serum: Potential role as a serum biomarker; citation_author=M.S. Derycke, S.E. Pambuccian, C.B. Gilks; citation_volume=134; citation_publication_date=2010; citation_pages=835-845; citation_doi=10.1309/AJCPGXK0FR4MHIHB; citation_id=CR45 citation_journal_title=Cancer Res.; citation_title=Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer; citation_author=A. Takano, N. Ishikawa, R. Nishino; citation_volume=69; citation_publication_date=2009; citation_pages=6694-6703; citation_doi=10.1158/0008-5472.CAN-09-0016; citation_id=CR46 citation_journal_title=Cancer Gene Ther.; citation_title=Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer; citation_author=R. Myers, S. Greiner, M. Harvey; citation_volume=12; citation_publication_date=2005; citation_pages=593-599; citation_doi=10.1038/sj.cgt.7700823; citation_id=CR47 citation_journal_title=BMC Cancer.; citation_title=Nectin-4 is a new histological and serological tumor associated marker for breast cancer; citation_author=S. Fabre-Lafay, F. Monville, S. Garrido-Urbani; citation_volume=7; citation_publication_date=2007; citation_pages=73; citation_doi=10.1186/1471-2407-7-73; citation_id=CR48 citation_title=The Paramyxoviruses; citation_publication_date=1991; citation_id=CR49; citation_author=D.W. Kingsbury citation_journal_title=J. Immunol.; citation_title=Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting; citation_author=M. Cohen, M. Elkabets, M. Perlmutter; citation_volume=185; citation_publication_date=2010; citation_pages=5869-5878; citation_doi=10.4049/jimmunol.1001635; citation_id=CR50 citation_journal_title=J. Immunol.; citation_title=Cell surface sialic acid influences tumor cell recognition in the mixed lymphocyte reaction; citation_author=L.D. Powell, S.W. Whiteheart, G.W. Hart; citation_volume=139; citation_publication_date=1987; citation_pages=262-270; citation_id=CR51 citation_journal_title=Clin. Pharmacol. Ther.; citation_title=Therapeutic potential of oncolytic measles virus: Promises and challenges; citation_author=E. Galanis; citation_volume=88; citation_publication_date=2010; citation_pages=620-625; citation_doi=10.1038/clpt.2010.211; citation_id=CR52 citation_journal_title=J. Virol.; citation_title=Assignment of disulfide bridges in the fusion glycoprotein of Sendai virus; citation_author=S. Iwata, A.C. Schmidt, K. Titani; citation_volume=68; citation_publication_date=1994; citation_pages=3200-3206; citation_id=CR53 citation_journal_title=J. Virol.; citation_title=Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity; citation_author=M. Tashiro, Y. Yokogoshi, K. Tobita; citation_volume=66; citation_publication_date=1992; citation_pages=7211-7216; citation_id=CR54 citation_journal_title=Eur. Respir. J.; citation_title=Sendai virus infection changes the subcellular localization of tryptase Clara in rat bronchiolar epithelial cells; citation_author=K. Sakai, T. Kohri, M. Tashiro; citation_volume=7; citation_publication_date=1994; citation_pages=686-692; citation_doi=10.1183/09031936.94.07040686; citation_id=CR55 citation_journal_title=J. Hostochem. Cytochem.; citation_title=Electron immunohistochemical localization in rat bronchiolar epithelial cells of tryptase Clara, which determines the pneumotropism and pathogenicity of Sendai virus and influenza virus; citation_author=K. Sakai, Y. Kawaguchi, Y. Kishino, H. Kido; citation_volume=41; citation_issue=1; citation_publication_date=1993; citation_pages=89-93; citation_doi=10.1177/41.1.8380186; citation_id=CR56 citation_journal_title=A pivotal role in the spread of infection, tissue tropism and pathogenicity. Microbiol. Immunol.; citation_title=Virus activation by host proteinases; citation_author=Y. Nagai; citation_volume=39; citation_publication_date=1995; citation_pages=1-9; citation_id=CR57 citation_journal_title=Biol. Chem.; citation_title=Molecular basis of proteolytic activation of Sendai virus infection and the defensive compounds for infection; citation_author=H. Kido, Y. Beppu, K. Sakai, T. Towatari; citation_volume=378; citation_publication_date=1997; citation_pages=255-263; citation_doi=10.1515/bchm.1997.378.3-4.255; citation_id=CR58 citation_journal_title=Trends Mol. Med.; citation_title=Type^II transmembrane serine proteases in cancer and viral infections; citation_author=S. Choi, S. Bertram, I. Glowacka; citation_volume=15; citation_publication_date=2009; citation_pages=303-312; citation_doi=10.1016/j.molmed.2009.05.003; citation_id=CR59 citation_journal_title=J. Virol.; citation_title=TMPRSS2 Is an activating protease for respiratory parainfluenza viruses; citation_author=M. Abe, M. Tahara, K. Sakai; citation_volume=87; citation_publication_date=2013; citation_pages=11930-11935; citation_doi=10.1128/JVI.01490-13; citation_id=CR60 citation_journal_title=J. Virol.; citation_title=TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells; citation_author=S. Bertram, I. Glowacka, P. Blazejewska; citation_volume=84; citation_publication_date=2010; citation_pages=10016-10025; citation_doi=10.1128/JVI.00239-10; citation_id=CR61 citation_journal_title=Cancer Res.; citation_title=Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth; citation_author=A. Bateman, F. Bullough, S. Murphy; citation_volume=60; citation_publication_date=2000; citation_pages=1492-1497; citation_id=CR62 citation_journal_title=Cancer Res.; citation_title=Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells; citation_author=A.R. Bateman, K.J. Harrington, T. Kottke; citation_volume=62; citation_publication_date=2002; citation_pages=6566-6578; citation_id=CR63 citation_journal_title=Cancer Gene Ther.; citation_title=Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: A potential therapy agent for lung cancer; citation_author=E. Lin, C. Salon, E. Brambilla; citation_volume=17; citation_publication_date=2010; citation_pages=256-265; citation_doi=10.1038/cgt.2009.74; citation_id=CR64 citation_journal_title=J. Virol.; citation_title=Membrane fusion-mediated autophagy induction enhances morbillivirus cell-to-cell spread; citation_author=S. Delpeut, P.A. Rudd, P. Labonte, V. Messling; citation_volume=86; citation_publication_date=2012; citation_pages=8527-8535; citation_doi=10.1128/JVI.00807-12; citation_id=CR65 citation_journal_title=Cancer Res.; citation_title=Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells; citation_author=M. Kurooka, Y. Kaneda; citation_volume=67; citation_publication_date=2007; citation_pages=227-236; citation_doi=10.1158/0008-5472.CAN-06-1615; citation_id=CR66 citation_journal_title=Cancer Immunol. Immunother.; citation_title=Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation; citation_author=A. Fujihara, M. Kurooka, T. Miki, Y. Kaneda; citation_volume=57; citation_publication_date=2008; citation_pages=73-84; citation_doi=10.1007/s00262-007-0351-y; citation_id=CR67 citation_title=RF Patent No. 2519763; citation_publication_date=2014; citation_id=CR68; citation_author=V. Senin; citation_author=A. Senina; citation_author=O. Matveeva citation_journal_title=Mol. Ther. Oncolytics.; citation_title=Oncolysis by paramyxoviruses: Preclinical and clinical studies; citation_author=O.V. Matveeva, Z.S. Guo, V.M. Senin; citation_volume=2; citation_publication_date=2015; citation_pages=15017; citation_doi=10.1038/mto.2015.17; citation_id=CR69 citation_journal_title=Med. Oncol. Tumor Pharmacother.; citation_title=A ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate; citation_author=W.A. Cassel, D.R. Murray; citation_volume=9; citation_publication_date=1992; citation_pages=169-171; citation_id=CR70 citation_journal_title=Mol. Med.; citation_title=A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire; citation_author=F.M. Batliwalla, B.A. Bateman, D. Serrano; citation_volume=4; citation_publication_date=1998; citation_pages=783-794; citation_doi=10.1007/BF03401771; citation_id=CR71 citation_journal_title=Cancer Detect. Prev.; citation_title=Attenuated veterinary virus vaccine for the treatment of cancer; citation_author=L.K. Csatary, S. Eckhardt, I. Bukosza, F. Czegledi, C. Fenyvesi, P. Gergely, B. Bodey, C.M. Csatary; citation_volume=17; citation_publication_date=1993; citation_pages=619-627; citation_id=CR72 citation_journal_title=J. Neurooncol.; citation_title=MTH-68/H oncolytic viral treatment in human high-grade gliomas; citation_author=L.K. Csatary, G. Gosztonyi, J. Szeberenyi, Z. Fabian, V. Liszka, B. Bodey, C.M. Csatary; citation_volume=67; citation_publication_date=2004; citation_pages=83-93; citation_doi=10.1023/B:NEON.0000021735.85511.05; citation_id=CR73 citation_journal_title=Mol. Ther.; citation_title=Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme; citation_author=A.I. Freeman, Z. Zakay-Rones, J.M. Gomori; citation_volume=13; citation_publication_date=2006; citation_pages=221-228; citation_doi=10.1016/j.ymthe.2005.08.016; citation_id=CR74 citation_journal_title=J. Clin. Oncol.; citation_title=Phase^I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers; citation_author=A.L. Pecora, N. Rizvi, G.I. Cohen; citation_volume=20; citation_publication_date=2002; citation_pages=2251-2266; citation_doi=10.1200/JCO.2002.08.042; citation_id=CR75 citation_journal_title=Clin. Cancer Res.; citation_title=A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization; citation_author=S.A. Laurie, J.C. Bell, H.L. Atkins; citation_volume=12; citation_publication_date=2006; citation_pages=2555-2562; citation_doi=10.1158/1078-0432.CCR-05-2038; citation_id=CR76 citation_journal_title=Curr. Cancer Drug Targets.; citation_title=Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus; citation_author=R.M. Lorence, M.S. Roberts, J.D. O’Neil; citation_volume=7; citation_publication_date=2007; citation_pages=157-167; citation_doi=10.2174/156800907780058853; citation_id=CR77 citation_journal_title=Clin. Cancer Res.; citation_title=An optimized clinical regimen for the oncolytic virus PV701; citation_author=S.J. Hotte, R.M. Lorence, H.W. Hirte; citation_volume=13; citation_publication_date=2007; citation_pages=977-985; citation_doi=10.1158/1078-0432.CCR-06-1817; citation_id=CR78 citation_journal_title=J. Clin. Oncol.; citation_title=Antitumor vaccination of patients with glioblastoma multiforme: A pilot study to assess feasibility, safety, and clinical benefit; citation_author=H.H. Steiner, M.M. Bonsanto, P. Beckhove; citation_volume=22; citation_publication_date=2004; citation_pages=4272-4281; citation_doi=10.1200/JCO.2004.09.038; citation_id=CR79 citation_journal_title=Cancer Res.; citation_title=Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virusmodified tumor cells; citation_author=J. Karcher, G. Dyckhoff, P. Beckhove; citation_volume=64; citation_publication_date=2004; citation_pages=8057-8061; citation_doi=10.1158/0008-5472.CAN-04-1545; citation_id=CR80 citation_journal_title=Adv. Otorhinolaryngol.; citation_title=Antitumor immunization of head and neck squamous cell carcinoma patients with a virusmodified autologous tumor cell vaccine; citation_author=C. Herold-Mende, J. Karcher, G. Dyckhoff, V. Schirrmacher; citation_volume=62; citation_publication_date=2005; citation_pages=173-183; citation_id=CR81 citation_journal_title=Cancer Immunol. Immunother.; citation_title=Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: Results of a prospective randomized trial; citation_author=T. Schulze, W. Kemmner, J. Weitz; citation_volume=58; citation_publication_date=2009; citation_pages=61-69; citation_doi=10.1007/s00262-008-0526-1; citation_id=CR82 citation_journal_title=Epidemiol. Vaktsinoprofilakt.; citation_title=Newcastle disease oncolytic virus and autologous tumor cells in complex cancer therapy; citation_author=V.B. Keshelava; citation_volume=3; citation_publication_date=2007; citation_pages=23-28; citation_id=CR83 citation_journal_title=Vestn. Ross. Nauch. Tsentra Rentgenoradiol.; citation_title=Organ-preserving treatment of breast cancer with the use of oncolytic Newcastle disease virus; citation_author=V.V. Keshelava, N.Y. Dobrovolskaya, M.V. Podolskaya, T.V. Gardarnik; citation_volume=9; citation_publication_date=2009; citation_pages=6; citation_id=CR84 citation_journal_title=Radiology–Practice.; citation_title=Efficacy of the integrated treatment of cervical cancer using the Newcastle disease virus; citation_author=V.V. Keshelava, N.Y. Dobrovolskaya, R.V. Stavitsky, M.V. Podolskaya; citation_volume=15; citation_publication_date=2010; citation_pages=38-45; citation_id=CR85 citation_journal_title=Blood.; citation_title=Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells; citation_author=L. Heinzerling, V. Kunzi, P.A. Oberholzer; citation_volume=106; citation_publication_date=2005; citation_pages=2287-2294; citation_doi=10.1182/blood-2004-11-4558; citation_id=CR86 citation_journal_title=Cancer Res.; citation_title=Phase^I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer; citation_author=E. Galanis, L.C. Hartmann, W.A. Cliby; citation_volume=70; citation_publication_date=2010; citation_pages=875-882; citation_doi=10.1158/0008-5472.CAN-09-2762; citation_id=CR87 citation_journal_title=Mayo Clin. Proc.; citation_title=Remission of disseminated cancer after systemic oncolytic virotherapy; citation_author=S.J. Russell, M.J. Federspiel, K.W. Peng; citation_volume=89; citation_publication_date=2014; citation_pages=926-933; citation_doi=10.1016/j.mayocp.2014.04.003; citation_id=CR88 citation_journal_title=Cancer Res.; citation_title=Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer; citation_author=E. Galanis, P.J. Atherton, M.J. Maurer; citation_volume=75; citation_publication_date=2015; citation_pages=22-30; citation_doi=10.1158/0008-5472.CAN-14-2533; citation_id=CR89 citation_journal_title=Cancer.; citation_title=Treatment of human cancer with mumps virus; citation_author=T. Asada; citation_volume=34; citation_publication_date=1974; citation_pages=1907-1928; citation_doi=10.1002/1097-0142(197412)34:6<1907::AID-CNCR2820340609>3.0.CO;2-4; citation_id=CR90 citation_journal_title=Biken J.; citation_title=Studies on the use of mumps virus for treatment of human cancer; citation_author=Y. Okuno, T. Asada, K. Yamanishi; citation_volume=21; citation_publication_date=1978; citation_pages=37-49; citation_id=CR91 citation_journal_title=Cancer Detect. Prev.; citation_title=Immunotherapy of advanced gynecologic cancer patients utilizing mumps virus; citation_author=Y. Shimizu, K. Hasumi, Y. Okudaira; citation_volume=12; citation_publication_date=1988; citation_pages=487-495; citation_id=CR92 citation_title=Newcastle disease virus (Paramyxoviridae); citation_publication_date=1999; citation_id=CR93; citation_author=P.T. Emmerson citation_journal_title=J. Am. Vet. Med. Assoc.; citation_title=Avian influenza and Newcastle disease; citation_author=D.E. Swayne, D.J. King; citation_volume=222; citation_publication_date=2003; citation_pages=1534-1540; citation_doi=10.2460/javma.2003.222.1534; citation_id=CR94 citation_journal_title=Proc. Soc. Exp. Biol. Med.; citation_title=Propagation of Newcastle disease virus in Ehrlich ascites cells in vitro and in vivo; citation_author=A.D. Flanagan, R. Love, W. Tesar; citation_volume=90; citation_publication_date=1955; citation_pages=82-86; citation_doi=10.3181/00379727-90-21945; citation_id=CR95 citation_journal_title=Expert Rev. Vaccines.; citation_title=Use of attenuated paramyxoviruses for cancer therapy; citation_author=P.J. Lech, S.J. Russell; citation_volume=9; citation_publication_date=2010; citation_pages=1275-1302; citation_doi=10.1586/erv.10.124; citation_id=CR96 citation_journal_title=Meth. Mol. Biol.; citation_title=Analysis of three properties of Newcastle disease virus for fighting cancer: Tumor-selective replication, antitumor cytotoxicity, and immunostimulation; citation_author=P. Fournier, H. Bian, J. Szeberenyi, V. Schirrmacher; citation_volume=797; citation_publication_date=2012; citation_pages=177-204; citation_doi=10.1007/978-1-61779-340-0_13; citation_id=CR97 citation_journal_title=Future Microbiol.; citation_title=Oncolytic Newcastle disease virus for cancer therapy: Old challenges and new directions; citation_author=D. Zamarin, P. Palese; citation_volume=7; citation_publication_date=2012; citation_pages=347-367; citation_doi=10.2217/fmb.12.4; citation_id=CR98 citation_journal_title=J. Biomed. Biotechnol.; citation_title=Safety and clinical usage of newcastle disease virus in cancer therapy; citation_author=H.Y. Lam, S.K. Yeap, M. Rasoli; citation_volume=718710; citation_publication_date=2011; citation_pages=26; citation_id=CR99 citation_journal_title=J. Surg. Res.; citation_title=Newcastle disease virus selectively kills human tumor cells; citation_author=K.W. Reichard, R.M. Lorence, C.J. Cascino; citation_volume=52; citation_publication_date=1992; citation_pages=448-453; citation_doi=10.1016/0022-4804(92)90310-V; citation_id=CR100 citation_journal_title=Int. J. Cancer.; citation_title=Tumor selective replication of Newcastle disease virus: Association with defects of tumor cells in antiviral defence; citation_author=C. Fiola, B. Peeters, P. Fournier; citation_volume=119; citation_publication_date=2006; citation_pages=328-338; citation_doi=10.1002/ijc.21821; citation_id=CR101 citation_journal_title=J. Virol.; citation_title=p53-independent endoplasmic reticulum stressmediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines; citation_author=Z. Fabian, C.M. Csatary, J. Szeberenyi, L.K. Csatary; citation_volume=81; citation_publication_date=2007; citation_pages=2817-2830; citation_doi=10.1128/JVI.02490-06; citation_id=CR102 citation_journal_title=Gene Ther.; citation_title=Human tumor cell modification by virus infection: An efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus; citation_author=V. Schirrmacher, C. Haas, R. Bonifer; citation_volume=6; citation_publication_date=1999; citation_pages=63-73; citation_doi=10.1038/sj.gt.3300787; citation_id=CR103 citation_journal_title=Mol. Ther.; citation_title=Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses; citation_author=D. Zamarin, L. Martinez-Sobrido, K. Kelly; citation_volume=17; citation_publication_date=2009; citation_pages=697-706; citation_doi=10.1038/mt.2008.286; citation_id=CR104 citation_journal_title=Anticancer Res.; citation_title=Induction of apoptosis by a Newcastle disease virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells; citation_author=Z. Fabian, B. Torocsik, K. Kiss; citation_volume=21; citation_publication_date=2001; citation_pages=125-135; citation_id=CR105 citation_journal_title=Am. J. Ther.; citation_title=Newcastle disease virus-induced apoptosis in PC12 pheochromocytoma cells; citation_author=J. Szeberenyi, Z. Fabian, B. Torocsik; citation_volume=10; citation_publication_date=2003; citation_pages=282-288; citation_doi=10.1097/00045391-200307000-00008; citation_id=CR106 citation_journal_title=J. Cancer Res. Clin. Oncol.; citation_title=The effect of a mesogenic and a lentogenic Newcastle disease virus strain on Burkitt lymphoma Daudi cells; citation_author=Y. Tzadok-David, M. Z.-R. Z. Metzkin-Eizenberg; citation_volume=121; citation_publication_date=1995; citation_pages=169-174; citation_doi=10.1007/BF01198099; citation_id=CR107 citation_journal_title=J. Cancer Res. Clin. Oncol.; citation_title=Preferential cytotoxic effect of Newcastle disease virus on lymphoma cells; citation_author=N. Bar-Eli, H. Giloh, M. Schlesinger, Z. Zakay-Rones; citation_volume=122; citation_publication_date=1996; citation_pages=409-415; citation_doi=10.1007/BF01212880; citation_id=CR108 citation_journal_title=J. Mol. Med.; citation_title=Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer; citation_author=K.Y. Song, J. Wong, L. Gonzalez; citation_volume=88; citation_publication_date=2010; citation_pages=589-596; citation_doi=10.1007/s00109-010-0605-6; citation_id=CR109 citation_journal_title=J. Natl. Cancer Inst.; citation_title=Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy; citation_author=R.M. Lorence, K.W. Reichard, B.B. Katubig; citation_volume=86; citation_publication_date=1994; citation_pages=1228-1233; citation_doi=10.1093/jnci/86.16.1228; citation_id=CR110 citation_journal_title=Cancer Res.; citation_title=Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy; citation_author=R.M. Lorence, B.B. Katubig, K.W. Reichard; citation_volume=54; citation_publication_date=1994; citation_pages=6017-6021; citation_id=CR111 citation_journal_title=Cancer Lett.; citation_title=Newcastle disease virus therapy of human tumor xenografts: Antitumor effects of local or systemic administration; citation_author=A. Phuangsab, R.M. Lorence, K.W. Reichard; citation_volume=172; citation_publication_date=2001; citation_pages=27-36; citation_doi=10.1016/S0304-3835(01)00617-6; citation_id=CR112 citation_journal_title=Cancer Res.; citation_title=Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus; citation_author=A. Vigil, M.S. Park, O. Martinez; citation_volume=67; citation_publication_date=2007; citation_pages=8285-8292; citation_doi=10.1158/0008-5472.CAN-07-1025; citation_id=CR113 citation_journal_title=Mol. Ther.; citation_title=Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma; citation_author=J. Altomonte, S. Marozin, R.M. Schmid, O. Ebert; citation_volume=18; citation_publication_date=2010; citation_pages=275-284; citation_doi=10.1038/mt.2009.231; citation_id=CR114 citation_journal_title=Meth. Mol. Biol.; citation_title=Newcastle disease virus: A promising vector for viral therapy, immune therapy, and gene therapy of cancer; citation_author=V. Schirrmacher, P. Fournier; citation_volume=542; citation_publication_date=2009; citation_pages=565-605; citation_doi=10.1007/978-1-59745-561-9_30; citation_id=CR115 citation_journal_title=Int. J. Oncol.; citation_title=Antitumor effects of Newcastle disease virus in vivo: Local versus systemic effects; citation_author=V. Schirrmacher, A. Griesbach, T. Ahlert; citation_volume=18; citation_publication_date=2001; citation_pages=945-952; citation_id=CR116 citation_journal_title=Curr. Opin. Mol. Ther.; citation_title=Overview of phase I studies of intravenous administration of PV701, an oncolytic virus; citation_author=R.M. Lorence, A.L. Pecora, P.P. Major; citation_volume=5; citation_publication_date=2003; citation_pages=618-624; citation_id=CR117 citation_title=Cancer: Realities and possibilities of application of the Newcastle disease virus; citation_inbook_title=Virotherapy: Rationale, Criteria, Indications of Use, Effectiveness; citation_publication_date=2014; citation_id=CR118; citation_author=V.B. Keshelava citation_title=Results of a study of the oncolytic Newcastle disease virus in neoadjuvant therapy for breast cancer over a 3-year follow-up period; citation_inbook_title=Vestn. Ross. Nauch. Tsentra Rentgenoradiol; citation_publication_date=2010; citation_id=CR119; citation_author=V.B. Keshelava citation_journal_title=Expert Opin. Biol. Ther.; citation_title=Oncolytic measles viruses for cancer therapy; citation_author=T. Nakamura, S.J. Russell; citation_volume=4; citation_publication_date=2004; citation_pages=1685-1692; citation_doi=10.1517/14712598.4.10.1685; citation_id=CR120 citation_journal_title=Curr. Gene Ther.; citation_title=Measles virus as an oncolytic vector platform; citation_author=B. Blechacz, S.J. Russell; citation_volume=8; citation_publication_date=2008; citation_pages=162-175; citation_doi=10.2174/156652308784746459; citation_id=CR121 citation_journal_title=Gene Ther.; citation_title=Oncolytic measles virus strains have significant antitumor activity against glioma stem cells; citation_author=C. Allen, M. Opyrchal, I. Aderca; citation_volume=20; citation_publication_date=2012; citation_pages=444-449; citation_doi=10.1038/gt.2012.62; citation_id=CR122 citation_journal_title=Development and preparations of the vaccine: Technics for assay of effects of vaccination. N. Engl. J. Med.; citation_title=Studies on an attenuated measles-virus vaccine: 1; citation_author=J.F. Enders, S.L. Katz, M.V. Milovanovic, A. Holloway; citation_volume=263; citation_publication_date=1960; citation_pages=153-159; citation_id=CR123 citation_journal_title=Blood.; citation_title=Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice; citation_author=D. Grote, S.J. Russell, T.I. Cornu; citation_volume=97; citation_publication_date=2001; citation_pages=3746-3754; citation_doi=10.1182/blood.V97.12.3746; citation_id=CR124 citation_journal_title=Blood.; citation_title=Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter; citation_author=D. Dingli, K.W. Peng, M.E. Harvey; citation_volume=103; citation_publication_date=2004; citation_pages=1641-1646; citation_doi=10.1182/blood-2003-07-2233; citation_id=CR125 citation_journal_title=Neuro Oncol.; citation_title=Treatment of medulloblastoma with a modified measles virus; citation_author=A.W. Studebaker, C.R. Kreofsky, C.R. Pierson; citation_volume=12; citation_publication_date=2010; citation_pages=1034-1042; citation_doi=10.1093/neuonc/noq057; citation_id=CR126 citation_journal_title=Cancer Res.; citation_title=Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme; citation_author=L.K. Phuong, C. Allen, K.W. Peng; citation_volume=63; citation_publication_date=2003; citation_pages=2462-2469; citation_id=CR127 citation_journal_title=Hepatology.; citation_title=Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma; citation_author=B. Blechacz, P.L. Splinter, S. Greiner; citation_volume=44; citation_publication_date=2006; citation_pages=1465-1477; citation_doi=10.1002/hep.21437; citation_id=CR128 citation_journal_title=Mol. Ther.; citation_title=Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter; citation_author=P. Msaouel, I.D. Iankov, C. Allen; citation_volume=17; citation_publication_date=2009; citation_pages=2041-2048; citation_doi=10.1038/mt.2009.218; citation_id=CR129 citation_journal_title=Breast Cancer Res. Treat.; citation_title=A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer; citation_author=C.J. McDonald, C. Erlichman, J.N. Ingle; citation_volume=99; citation_publication_date=2006; citation_pages=177-184; citation_doi=10.1007/s10549-006-9200-5; citation_id=CR130 citation_journal_title=Breast Cancer Res. Treat.; citation_title=Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model; citation_author=I.D. Iankov, P. Msaouel, C. Allen; citation_volume=122; citation_publication_date=2010; citation_pages=745-754; citation_doi=10.1007/s10549-009-0602-z; citation_id=CR131 citation_journal_title=Cancer Gene Ther.; citation_title=Pharmacokinetics of oncolytic measles virotherapy: Eventual equilibrium between virus and tumor in an ovarian cancer xenograft model; citation_author=K.W. Peng, E.M. Hadac, B.D. Anderson; citation_volume=13; citation_publication_date=2006; citation_pages=732-738; citation_doi=10.1038/sj.cgt.7700948; citation_id=CR132 citation_journal_title=Biology.; citation_title=Antitumor virotherapy by attenuated measles virus; citation_author=G. Guillerme, M. Tangy, F. Fonteneau; citation_volume=2; citation_publication_date=2013; citation_pages=587-602; citation_doi=10.3390/biology2020587; citation_id=CR133 citation_journal_title=Curr. Opin. Mol. Ther.; citation_title=Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview; citation_author=P. Msaouel, A. Dispenzieri, E. Galanis; citation_volume=11; citation_publication_date=2009; citation_pages=43-53; citation_id=CR134 citation_title=Infectious Diseases of Mice and Rats; citation_publication_date=1991; citation_id=CR135 citation_journal_title=J. Virol.; citation_title=A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-tocell spreading; citation_author=M. Inoue, Y. Tokusumi, H. Ban; citation_volume=77; citation_publication_date=2003; citation_pages=6419-6429; citation_doi=10.1128/JVI.77.11.6419-6429.2003; citation_id=CR136 citation_journal_title=Front. Biosci.; citation_title=Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen; citation_author=Y. Yonemitsu, Y. Ueda, H. Kinoh, M. Hasegawa; citation_volume=13; citation_publication_date=2008; citation_pages=1892-1898; citation_doi=10.2741/2809; citation_id=CR137 citation_journal_title=Clin. Cancer Res.; citation_title=Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats; citation_author=Y. Iwadate, M. Inoue, T. Saegusa; citation_volume=11; citation_publication_date=2005; citation_pages=3821-3827; citation_doi=10.1158/1078-0432.CCR-04-1485; citation_id=CR138 citation_journal_title=Acta Naturae; citation_title=Mechanisms of oncolysis by paramyxovirus Sendai; citation_author=O.V. Matveeva, G.V. Kochneva, S.V. Netesov; citation_volume=7; citation_issue=2; citation_publication_date=2015; citation_pages=6-17; citation_id=CR139 citation_journal_title=Cancer Gene Ther.; citation_title=Recent advances and developments in the antitumor effect of the HVJ envelope vector on malignant melanoma: from the bench to clinical application; citation_author=A. Tanemura, E. Kiyohara, I. Katayama, Y. Kaneda; citation_volume=20; citation_publication_date=2013; citation_pages=599-605; citation_doi=10.1038/cgt.2013.61; citation_id=CR140 citation_journal_title=Vaccine.; citation_title=Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults; citation_author=K.S. Slobod, J.L. Shenep, J. Lujan-Zilbermann; citation_volume=22; citation_publication_date=2004; citation_pages=3182-3186; citation_doi=10.1016/j.vaccine.2004.01.053; citation_id=CR141